RecruitingPhase not listed

Rutgers University Study of the Genetics of Blood Cancers

The Rutgers University Study of the Genetics of Blood Cancers

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years to 110 Years
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "The goal of this study is to enroll at least 10,000 participants nationally including affecteds and unaffecteds via online study portal, collect surveys online and a saliva sample through the mail, sequence DNA, and conduct genetic analyses to identify novel variants and further study known variants associated with leukemia, lymphoma, myeloma and other blood cancers."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study looks for changes in DNA linked to blood cancers, such as leukemia, lymphoma, and myeloma. It is for adults living in the United States, with or without blood cancer. Participants fill out an online health survey and mail in a saliva (spit) sample for DNA testing.

The goal of this study is to enroll at least 10,000 participants nationally including affecteds and unaffecteds via online study portal, collect surveys online and a saliva sample through the mail, sequence DNA, and conduct genetic analyses to identify novel variants and further study known variants associated with leukemia, lymphoma, myeloma and other blood cancers.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • You are 18 or older.
  • You currently live in the United States.
  • You have internet access and a computer, laptop, tablet, or smartphone.
  • You are willing to give written consent, meaning you agree to join after learning about the study.
  • You are willing to give a saliva (spit) sample for DNA testing using a kit mailed to your home.
  • You are willing to answer a health survey related to blood cancer.

Who can't join

  • You cannot meet all of the requirements listed above.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * age 18 years or older * currently living in the United States * have access to the internet and a computer, laptop, tablet or smartphone * willing to provide written informed consent for participation * willing to provide DNA via a saliva sample using a collection kit mailed to your home * willing to complete a survey with questions about health related to the study of blood cancer. Exclusion Criteria: * Not able to meet or fulfill any of the inclusion criteria

Study sites (1)

NJ